On March 7, 2023 Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
On November 8, 2022 Lyophilization process engineering and thermostability of ID93 + GLA-SE, a single-vial adjuvanted subunit tuberculosis vaccine candidate for use in clinical studies
On November 2, 2022 A self-amplifying RNA vaccine against COVID-19 with long-term room-termperature stability
On March 19, 2021 Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying